WASHINGTON, D.C. – The MedTech Conference – North America’s premier annual gathering for medical technology executives and professionals – will again be host to the grand finals of the MedTech Innovator competition when the conference meets this year in Philadelphia on Sept. 24-26.
Press Release | June 14, 2018
Press Release | June 13, 2018
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on FDA's release of final guidance on medical device communications:
Blog Post | June 8, 2018
For the past several years, policymakers and industry have been exploring ways to improve the quality of health care furnished to individuals while promoting efficiency and value. As I have discussed in the past, I believe that medical technology companies can be a key player in these coordinated care efforts in light of their specialized clinical knowledge, economic expertise, data analytics proficiency, and supply chain management capability. Unfortunately, various regulatory roadblocks stand in the way of the medtech industry’s full participation in the shift to more coordinated care.
September 11, 2018 to September 12, 2018| Minneapolis, MN
Save $200 with early bird pricing! During this workshop, you will be provided with the road-map and practical applications to successfully navigate the many potential reimbursement pitfalls. After... Read More
September 12, 2018 to September 13, 2018| Minneapolis, MN
Save $100 with early bird pricing! This next level reimbursement workshop was created with the more advanced professional in mind. You'll walk away from this workshop with more insight into the... Read More
September 24, 2018 to September 26, 2018| Philadelphia, PA
The MedTech Conference is your opportunity to connect with thousands of medical technology professionals in one place, at one time. Join us in Philadelphia for business development, innovative... Read More
October 15, 2018 to October 16, 2018| Washington, DC
Save $200 with early bird pricing! FDA and industry experts are coming together to teach you the basics of 510(k) submissions. This unique opportunity will help you better understand the FDA... Read More
Antibiotic resistance is one of the biggest threats to global health according to the World Health Organization (WHO). Learn about the important role that diagnostic tests play in combatting antibiotic resistance.
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...
Helius Medical Technologies, Inc. Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock and Warrants
Helius Medical Technologies, Inc.
NEWTOWN, PA., April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions. The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States.
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
June 22, 2018 - 12:55pm
June 21, 2018 - 3:25pm
Advanced medical technology such as intraocular lenses can help to minimize or even eliminate dependence on eyeglas… https://t.co/RklHYDSUZe